Treating Heart Failure with a Diabetes Medication: Empagliflozin Shines in Phase III Clinical Trial
The EMPEROR-Reduced Phase III clinical trial by Boehringer Ingelheim and Eli Lilly and Company found that empagliflozin, a diabetes medication, is a safe and effective treatment for heart failure...